Deals Of The Week: GSK/Cellzome, AZ/Torrent, Abbott/Facet Biotech...
Executive Summary
Each week, "The Pink Sheet" presents commentary on some of the week's most interesting business deals, contributed by the editors of the IN VIVO blog. Visit the blog at 1http://invivoblog.blogspot.com
You may also be interested in...
Facet Cuts Shareholder Deals To Fight Off Hostile Biogen Bid
Biogen Idec will drop its $450 million tender offer, but the companies still must work together to develop two key drugs.
Indian Drug Firms Realign Marketing Structures For More Profitability And Cost Savings
MUMBAI - Impending risk from loss of market share and fewer products in their pipelines are pushing small and medium-sized Indian drug makers to restructure their marketing operations
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011